ClinicalTrials.gg
CompletedNCT06815523PREMIERUpdated Jul 8, 2026

Prediction of Duration of Mechanical Ventilation in Acute Hypoxemic Respiratoty Failure

An observational study in Acute Hypoxemic Respiratory Failure, sponsored by Jesus Villar. Completed at 2 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by Jesus Villar · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,241
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 69 studies in Respiratory Insufficiency with a site in Spain — 11 open to participants now, 15 under way, none of them phase 3. Respiratory Insufficiency · Spain.

Enrollment
6th of 31
1,241 · median 298
Started
2025
with 4 others
Observational
31 of 69
5 open now
Registered
56th of 69
by date
Lead sponsor
2 of 69
Jesus Villar

Among the 69 studies in Respiratory Insufficiency with a site in Spain, this one is the 6th largest by enrollment of the 31 observational ones that give a count, is one of 5 that started in 2025, is one of 31 observational ones, and was the 56th registered.

Respiratory Insufficiency

1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.

Browse Respiratory Insufficiency studies →

Open to participants now

11 of the 69 studies in Respiratory Insufficiency with a site in Spain are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 69 studies in Respiratory Insufficiency with a site in Spain, or all of them as a file.
02

Study summary

Acute hypoxemic respiratory failure (AHRF) is a common cause of admission in intensive care units (ICUs) worldwide. We will assess machine learning (ML) techniques for prediction of prolonged duration (> or = to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. The study was registered with ClinalTrials.gov (NCT03145974). Our aim is to identify a model with the minimum number of variables that predict duration of prolonged ventilation in AHRF patients using data as early as from the first 48 hours with machine learning algorithms.

Read the detailed description

Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in intensive care units (ICUs) worldwide. The investigators will assess the value of machine learning (ML) techniques for prediction of prolonged duration (> or equeal to 7 days) of mechanical ventilation (MV) in 1,241 patients enrolled in the PANDORA study in Spain. Few studies have investigated the prediction of prolonged MV in patients with AHRF.

For model training and testing, the investigators will extract data from random pateints from the first 2 days after diagnosis of AHRF. The investigators had a database with 2,000,000 anonymized and dissociated demographics and clinically relevant data from 1,241 patients with AHRF from 22 hospitals in Spain. The investigators will follow the TRIPOD guidelines for prediction models. The investigators will screen relevant collected variables using a genetic algorithm variable selection to achieve parsimony. We will use 5-fold corss-validation in the data set of patients with data at T0, T24 and T48. We will use 25% of patients randomly selected for evaluation of the model.

03

Conditions studied

  • Acute Hypoxemic Respiratory Failure

Keywords

  • mechanical ventilation
  • machine learning
  • prediction of prolonged mechanical ventilation
  • outcome
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

De-identified dataset inclusing 1241 ventilated patients with AHRF admitted in a network of Spainisg ICUs.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • enotracheal intubation puls mechanical ventilation
  • PaO2/FiO2 ratio \<or = 300 mmHg under MV with PEEP >or =5 and FiO2 >or = 0.3

Exclusion criteria

Exclusion Criteria:

  • Brain death patients
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,241 participants (actual)
Patient registry
No

Groups and cohorts

  • Derivation/testing cohort

    The investigators will use a chort of 75% of patients, randomly selected, with data at T0, T24 and T48 after diagnosis of acute hypoxemic respiratory failure (AHRF). We will apply machine learning approaches.

    Other: Machine learning and logistic regression for the training/testing cohort and validation cohort

  • Validation hohort

    we will use 25% of unseen patients, randomly selected, with data at T0, T24 and T48 after diagnosis of AHRF.

    Other: Machine learning and logistic regression for the training/testing cohort and validation cohort

Interventions

  • OtherMachine learning and logistic regression for the training/testing cohort and validation cohort

    Machine learning and logistic regression for the validation cohort

06

What researchers measure

Primary outcomes

  1. MV duration

    duration of mechanical ventilation

    Time frame: up to 100 weeks

07

Study locations

2 sites
  • Hospital Dr. Negrin
    Las Palmas de Gran Canaria, Las Palmas 35019, Spain
  • Hospital Universitario La Paz
    Madrid, Spain
08

References and documents

Publications

  • Villar J, Gonzalez-Martin JM, Fernandez C, Soler JA, Rey-Abalo M, Mora-Ordonez JM, Ortiz-Diaz-Miguel R, Fernandez L, Murcia I, Robaglia D, Anon JM, Ferrando C, Parrilla D, Dominguez-Berrot AM, Cobeta P, Martinez D, Amaro-Harpigny A, Andaluz-Ojeda D, Fernandez MM, Gomez-Bentolila E, Steyerberg EW, Camporota L, Szakmany T. Predicting Outcome and Duration of Mechanical Ventilation in Acute Hypoxemic Respiratory Failure: The PREMIER Study. J Clin Med. 2025 Nov 7;14(22):7903. doi: 10.3390/jcm14227903. PubMed 41302939 ↗

Individual participant data

Plan to share: No — Ethical reasons

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2025 to primary completion in May 2026, 14 months.

Of 232 non-industry observational studies under Respiratory Insufficiency, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's 14 months is below that.

Counting every sponsor, half of 248 studies reached it within 22 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 7, 2025
StartActual
Feb 2, 2025
Primary completionActual
May 1, 2026
CompletionActual
Jun 1, 2026
Last update
Jul 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06815523
Lead sponsor
Jesus Villar
Collaborators
Hospital Universitario de Gran Canaria Doctor Negrín, Instituto de Salud Carlos III
Responsible party
Jesus Villar (Scientific Advisor, Hospital Universitario de Gran Canaria Doctor Negrín) — Sponsor-investigator
First posted
Feb 7, 2025
Start date
Feb 2, 2025
Primary completion
May 1, 2026
Completion
Jun 1, 2026
Last update
Jul 8, 2026

Study contacts

Jesus Villar
study director · Fundacion Canaria Instituto de Investigación Sanitaria de Canarias

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion